Jason N. Butler
Stock Analyst at Citizens
(3.73)
# 725
Out of 5,067 analysts
10
Total ratings
60%
Success rate
9.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $28.32 | +182.49% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $12.63 | +74.19% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $9.77 | +74.00% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $125.71 | -9.32% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $9.82 | +124.03% | 1 | Sep 9, 2025 | |
| CYTK Cytokinetics | Reiterates: Market Outperform | $78 | $67.21 | +16.05% | 1 | Sep 2, 2025 | |
| PGEN Precigen | Maintains: Market Outperform | $6 → $8 | $3.82 | +109.42% | 1 | Aug 19, 2025 | |
| ZVRA Zevra Therapeutics | Maintains: Market Outperform | $19 → $18 | $8.65 | +108.09% | 1 | Aug 13, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $30 → $35 | $23.90 | +46.44% | 1 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Market Outperform | $91 → $78 | $74.00 | +5.41% | 1 | Aug 6, 2025 |
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $28.32
Upside: +182.49%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $12.63
Upside: +74.19%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $9.77
Upside: +74.00%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $125.71
Upside: -9.32%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $9.82
Upside: +124.03%
Cytokinetics
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $67.21
Upside: +16.05%
Precigen
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $3.82
Upside: +109.42%
Zevra Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $8.65
Upside: +108.09%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Market Outperform
Price Target: $30 → $35
Current: $23.90
Upside: +46.44%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $74.00
Upside: +5.41%